ASX Announcement

ALA files IND with the U.S. FDA for phase 1 clinical trial

Published: 30/12/25, 12:18pm (AEST)2 pages
Arovella Therapeutics
ALA:ASXHealthcare

Recent ALA Announcements

Price Sensitive only